| 注册
首页|期刊导航|同济大学学报(医学版)|银屑病靶向外用药物的研究进展

银屑病靶向外用药物的研究进展

黄韬

同济大学学报(医学版)2018,Vol.39Issue(2):22-25,4.
同济大学学报(医学版)2018,Vol.39Issue(2):22-25,4.DOI:10.16118/j.1008-0392.2018.02.005

银屑病靶向外用药物的研究进展

Research advances of topical treatment of psoriasis

黄韬1

作者信息

  • 1. 同济大学附属第十人民医院皮肤科,上海200072
  • 折叠

摘要

Abstract

In recent years, the research progresses in immunological mechanisms of psoriasis and genetic engineering have brought the prospect in treatment of psoriasis. Several new agents selectively targeting the small molecules of cytokines and signaling pathways are available. The phase I and II clinical trials on inhibitors of JAK/STAT, PED4, IRS-1,VEGF receptors and TrkA are underway, which would provide more choices for topical treatment of psoriasis in the future.

关键词

银屑病/外用药/信号通路/小分子抑制剂

Key words

psoriasis/topical treatment/signaling pathways/small molecules inhibitor

分类

医药卫生

引用本文复制引用

黄韬..银屑病靶向外用药物的研究进展[J].同济大学学报(医学版),2018,39(2):22-25,4.

基金项目

国家自然科学基金(81673050,81301356) (81673050,81301356)

上海市自然科学基金(16ZR1426800) (16ZR1426800)

同济大学学报(医学版)

OACSTPCD

1008-0392

访问量0
|
下载量0
段落导航相关论文